TENET HEALTHCARE CORP

NYSE: THC·Dallas, Texas·

Price
$291.54
Base IV
$487.95

Valuation snapshot

Below bear case

At $291.54, the price is below even our bear case of $334.43.

Values per share, from an .

No growth
…
Loading earnings power
Base case
$487.95
above today's price · range $334.43–$642.55
Price vs base case
40% below
$291.54 against $487.95
Base casevalued by DCF
Price vs base
Priceclose 11‑16

The price has risen 7.8% since this valuation was struck on 2026-10-31, so some of the gap opened up after these figures were set.

Whisker on the base case runs bear $334.43 to bull $642.55. Values per share.

Price against each value

Bear case
$334.43
Price 13% below
No growth
…
—
Base case
$487.95
Price 40% below
Researched bygemini-3.8-flash-medium
Valuation Oct 31, 2026 · Price as of Nov 16, 2026How we got here

What does Tenet Healthcare do?

Tenet Healthcare provides acute care and ambulatory surgery services to patients through a network of hospitals and surgery centers, while offering revenue cycle management services to healthcare providers.

It brought in $22.2B of sales in the 12 months to Sep 2026.

Detroit Receiving Hospital, an acute care hospital operated by Tenet HealthcareCC BY-SA 3.0, via Wikimedia Commons
Industry
Healthcare
Based in
Dallas, Texas
Trades on
NYSE as THC

Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Sep 2026, about 13¢ was left as profit after every cost, interest and tax. The biggest cost is running the business, 76¢ of every dollar.

  • Running the business76¢
  • Interest and other costs7¢
  • Tax4¢
  • Left as profit13¢
Totals of the four quarters to Sep 2026, from the company's own filings. The split by product is from the latest fiscal year.

Who pays Tenet Healthcare, and for what?

Tenet Healthcare operates acute care hospitals, outpatient facilities, and ambulatory surgery centers across the United States. It provides general, specialty, and surgical medical care to patients, while also offering revenue cycle management services to healthcare systems.

Tenet is paid by commercial health insurers, government healthcare programs including Medicare and Medicaid, and individual patients.

  • Hospital Operations

    74%

    General acute care and specialty hospitals, physician practices, urgent care centers, imaging facilities, and Conifer revenue cycle services.

    Detroit Receiving Hospital, an acute care hospital operated by Tenet HealthcareCC BY-SA 3.0, via Wikimedia Commons
  • Ambulatory Care

    26%

    Ambulatory surgery centers and surgical hospitals operated through USPI providing specialized same-day surgeries and procedures.

Share of the latest fiscal year's sales, as the company reports it.

Tenet Healthcare Corp 2025 Form 10-K

How is the business doing?

Sales grew from $17.6B in 2020 to $21.3B in 2025, about 4% a year.

Running the business leaves about 24¢ of each sales dollar as operating profit, up from 11¢ in 2020.

After paying for its upkeep and new investment, it had $3.3B of cash to spare in the 12 months to Sep 2026.

Sales$21.3B
20172025
Operating margin16%
20172025
Free cash flow$2.5B
20172025
Each bar is one fiscal year (2017–2025), summed from four published quarters; the latest is highlighted.

What does management say it's aiming for?

The company exists to deliver high-quality, compassionate medical care to the local communities it serves.

“to provide quality, compassionate care in the communities we serve.”

Tenet Healthcare Corp 2025 Form 10-K

What management says it is working on now:

  • Expanding Ambulatory Care

    Growing the USPI ambulatory network by acquiring surgical centers, opening new locations, and broadening physician partnerships.

    Tenet Healthcare Corp 2025 Form 10-K
  • Higher-Acuity Hospital Growth

    Investing in high-demand specialty services such as advanced cardiac care, robotic surgery, orthopedics, and neurosciences.

    Tenet Healthcare Corp 2025 Form 10-K
  • Operational Efficiency and AI Adoption

    Deploying artificial intelligence tools for documentation and revenue cycle management while managing labor and supply expenses.

    Tenet Healthcare Corp 2025 Form 10-K
  • Balance Sheet Optimization

    Refinancing near-term borrowings with long-term debt and returning capital to shareholders via share buybacks.

    Tenet Healthcare Corp 2025 Form 10-K
Net Operating Revenues, FY 2026
$22.05B to $22.45B
Tenet Healthcare Third Quarter 2026 Results
Consolidated Adjusted EBITDA, FY 2026
$5.05B to $5.20B
Tenet Healthcare Third Quarter 2026 Results
Adjusted Diluted Earnings Per Share, FY 2026
$22.05 to $23.01
Tenet Healthcare Third Quarter 2026 Results
Adjusted Free Cash Flow, FY 2026
$2.825B to $3.125B
Tenet Healthcare Third Quarter 2026 Results
Goals in management's own numbers. A target is a promise, not a result.

What's changing right now?

Growth is holding steady. In Q3 2026 it sold 6% more than a year earlier. The year before, quarters averaged 5%.

Its operating margin is wider than a year ago: 31¢ per sales dollar, against 17¢.

Since Oct 2026 the share price has risen 8%, from $270.57 to $291.54.

Bull $642.55Base $487.95Bear $334.43Oct 30Nov 16 · $291.54
Daily closing prices we have recorded, set against our bear-to-bull range. Our price records start October 30, 2026.

Coming up

  • December 31, 2026

    Conifer CHI Contract Termination

    Conifer's master services agreement providing revenue cycle management to CommonSpirit Health facilities ends, shifting client mix and operations.

    Tenet Healthcare Corp 2025 Form 10-K
  • 2026 to 2028

    CommonSpirit Health Multi-Year Settlement Installments

    CommonSpirit Health pays the remaining installments of the agreed $1.9 billion aggregate settlement in annual payments.

    Tenet Healthcare Corp 2025 Form 10-K
  • May 31, 2027

    Desert Regional Medical Center Lease-Purchase Transition

    Current operating lease expires and transitions to a new 30-year lease-purchase agreement leading to eventual hospital ownership.

    Tenet Healthcare Corp 2025 Form 10-K
  • Beginning 2027

    Implementation of Federal OBBBA Healthcare Reforms

    Key provisions of the One Big Beautiful Bill Act take effect, introducing new Medicaid eligibility rules and caps on state-directed payments.

    Tenet Healthcare Corp 2025 Form 10-K

What could go wrong?

No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.

  1. Managed Care Reimbursement Pressures

    Consolidation among private health insurers increases their bargaining leverage, which could reduce payment rates and increase claim denials.

    From the company's own filingsWould hit how fast sales growTenet Healthcare Corp 2025 Form 10-K

  2. Healthcare Policy and Medicaid Funding Changes

    Changes to federal and state health legislation, such as the One Big Beautiful Bill Act, could reduce Medicaid payments and coverage eligibility.

    From the company's own filingsWould hit how fast sales growTenet Healthcare Corp 2025 Form 10-K

  3. Clinical Staffing Shortages and Rising Wage Costs

    Shortages of specialized nurses and healthcare professionals, alongside minimum wage increases, can elevate labor and contract staffing expenses.

    From the company's own filingsWould hit how much of each sale it keepsTenet Healthcare Corp 2025 Form 10-K

  4. Physician Recruitment and Retention

    Failure to attract and retain skilled physicians may lead to lower patient admissions and fewer surgical procedures at facilities.

    From the company's own filingsWould hit how fast sales growTenet Healthcare Corp 2025 Form 10-K

  5. Cybersecurity Vulnerabilities and IT Disruptions

    Cyberattacks or data breaches targeting critical hospital or vendor systems could compromise confidential patient records and interrupt patient care.

    From the company's own filingsWould hit how much of each sale it keepsTenet Healthcare Corp 2025 Form 10-K

  6. Infectious Disease Outbreaks

    Epidemics or public health emergencies can strain facility resources, inflate medical supply costs, and trigger cancellations of elective surgeries.

    From the company's own filingsWould hit how fast sales growTenet Healthcare Corp 2025 Form 10-K

  7. Year-over-year revenue comparisons in 2027 will be burdened by the absence of $450 million in EBITDA and $646 million in revenue recognized during 2026 from Conifer contract transitions.

    From our researchWould hit how fast sales growTenet Healthcare Q3 2026 Earnings Call Transcript

  8. Hospital operating margin remains vulnerable to nurse wage re-benchmarking and medical implant price inflation in acute care facilities.

    From our researchWould hit how much of each sale it keepsTenet Healthcare Form 10-Q Risk Factors

Is it a good business?

From 2017 to 2025 it earned between 6% and 32% on the capital invested in it, a median of 12%. Its cost of capital in the latest valuation is 7.8%; returns were above it in 8 of the 9 years.

From 2020 to 2025 it earned between 33% and 1,425% on its shareholders' equity, a median of 57%.

Over 9 years its operating margin ranged from 6¢ to 29¢ per sales dollar, a median of 12¢.

derived computed from the filingsassumption cost of capital from the latest valuation
Return on invested capital19%
20172025

Cost of capital 7.8%

Return on equity33%
20172025
Return on invested capital is operating profit after tax (at the median effective rate, 23%) over debt plus equity less cash at each fiscal year end. Return on equity is net income over equity. Both are computed from published quarters.

It bought back shares: the count fell 9.0% in a year, so each remaining share owns a slightly bigger slice.

It owes $10.6B more than it holds in cash, about 2.0 years of operating profit.

What might it be worth?

The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .

Today a share costs $291.54. Our put its value between $334.43 and $642.55, with $487.95 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .

Bear case, $334.43

This conservative scenario reflects sales shrinking slightly after temporary contract gains wear off, while hospital wage pressures and insurance pushback push profit percentages back toward their previous sixteen percent level.

Base case, $487.95

This baseline scenario projects steady three to four percent yearly sales expansion as higher-profit surgical centers expand and acute care hospital visits grow modestly, allowing core profitability to hold near nineteen percent after temporary transition fees expire.

Bull case, $642.55

This optimistic scenario envisions robust four to five percent revenue expansion propelled by rapid surgical center acquisitions and rising high-demand orthopedic surgeries, lifting overall business profitability toward twenty-two percent.

Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.

Why the gap?

The price expects less than we do.Margin of safety: 40%

At today's $291.54, the price makes sense if sales shrink about 5.2% a year. We assume they grow 3.3%. Over the last 5 years, sales grew 2.5% a year.

−8%−6%−4%−2%0%+2%+4%+6%Price needs −5.2%Past 5 yrs 2.5%We assume 3.3%

Or, if sales grow 3.3% as we assume, the price works with a profit margin of 13.0% (we assume 19.0%).

Keep in mind: a low price can mean investors see a risk that isn't in the filings yet. Check the Full research tab for what could go wrong.

Do you think sales will shrink?

Try your own numbers

We're moderately sure of this range: it scores 68 out of 100 on our checks. The weakest point is terminal-value dependency.

Test the assumptions

Our base value of $487.95 rests on three assumptions. Change any of them to see how the value per share responds.

  • Revenue growth, 5-year average3.3%
  • Operating margin19.0%
  • Long-term growth rate2.4%

This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.

Base estimate

$487.95 67.4%

Build